AGI-5198 from ABBEXA LTD

Search, find, compare suppliers for AGI-5198 products.

Edit 
Product NameAGI-5198
DescriptionAGI-5198 is a small molecule which can act as a R132 mutant isocitrate dehydrogenase inhibitor. It is provided as a powder.

This product acts on the following target types: Dehydrogenase (GAPDH, GPDH, IMPDH, PHGDH, LDH, DHODH, ALDH, GDH, IDH, UGDH, DPD, DHPDH, and MDH).
This product acts on the following biochemical pathways: Mitochondrial function, NADH.
This product may be of interest in the following research areas and diseases: Cancer.

Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 462.56 g/mol
Size5 mg, 25 mg
Concentrationn/a
Applicationsn/a
Other NamesAGI-5198, N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide, 1355326-35-0
Gene, Accession, CAS #CAS: 1355326-35-0
Catalog #abx283066
Priceplease inquire
Order / More InfoAGI-5198 from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.